Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

VJOncology was excited to interview experts who presented at ESTRO 2025! This global conference focused on updates and the latest guidelines in the field of radiotherapy. Stay tuned for our in-depth coverage!

ESTRO 2025

02–06 May 2025 | Vienna, Austria

ESTRO 2025

02–06 May 2025 | Vienna, Austria
VJOncology was excited to interview experts who presented at ESTRO 2025! This global conference focused on updates and the latest guidelines in the field of radiotherapy. Stay tuned for our in-depth coverage!
BRCA mutation management and breast cancer treatment options 1:19
BRCA mutation management and breast cancer treatment options
Icro Meattini • 30 May 2025
Limited role of biomarker-driven tools in radiotherapy decision-making for breast cancer 1:55
Limited role of biomarker-driven tools in radiotherapy decision-making for breast cancer
Icro Meattini • 30 May 2025
The role of biomarker-driven tools in optimizing radiotherapy for breast cancer 1:13
The role of biomarker-driven tools in optimizing radiotherapy for breast cancer
Icro Meattini • 30 May 2025
BRCA carrier status and radiation therapy in young patients with breast cancer 2:34
BRCA carrier status and radiation therapy in young patients with breast cancer
Icro Meattini • 30 May 2025
Moderate hypofractionation in high-risk breast cancer 3:07
Moderate hypofractionation in high-risk breast cancer
Icro Meattini • 30 May 2025
BRCA1 and BRCA2 carrier status: implications for breast cancer treatment 1:28
BRCA1 and BRCA2 carrier status: implications for breast cancer treatment
Icro Meattini • 30 May 2025
PLATO ACT 4: reducing radiotherapy dose in early-stage anal cancer maintains local RFS 4:17
PLATO ACT 4: reducing radiotherapy dose in early-stage anal cancer maintains local RFS
Maria Antonietta Gambacorta • 12 May 2025
STAR-TREC: evaluating organ preservation in patients with early intermediate rectal cancer 9:54
STAR-TREC: evaluating organ preservation in patients with early intermediate rectal cancer
Maria Antonietta Gambacorta • 12 May 2025
MITO-RT3/RAD: treating oligometastatic parenchymal lesions in ovarian cancer with SBRT 3:37
MITO-RT3/RAD: treating oligometastatic parenchymal lesions in ovarian cancer with SBRT
Maria Antonietta Gambacorta • 12 May 2025
The content of VJOncology is intended for healthcare professionals